{"id":"etifelmine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"etifelmin","offLabel":[],"synonyms":["etifelmine hydrochloride","etifelmin","etifelmine","etifelmine HCl"],"timeline":[],"approvals":[],"brandName":"Etifelmin","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a city with many different roads and intersections. Etifelmin is like a traffic cop that helps direct the flow of traffic, but we don't know which specific roads or intersections it's controlling. This helps to explain how it might affect the body's functions, but more research is needed to understand its full effects.","oneSentence":"Etifelmin works by interacting with specific biological pathways, but the exact mechanism is unknown.","technicalDetail":"Etifelmin's mechanism of action is currently unknown, and further research is needed to determine its pharmacological effects on the body."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3741","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ETIFELMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:17:01.833331","biosimilars":[],"competitors":[],"genericName":"etifelmine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"1ZFB1FR98E","CHEBI":"CHEBI:31581","INN_ID":"2694","UMLSCUI":"C1880580","ChEMBL_ID":"CHEMBL2104621","KEGG_DRUG":"D01837","PUBCHEM_CID":"68840","SECONDARY_CAS_RN":"1146-95-8"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Etifelmin (ETIFELMINE) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is unknown. Further research is needed to determine its efficacy and safety profile. The lack of information on its pharmacokinetics and patent status makes it difficult to assess its current status in the market.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}